Research Calls I
-
Upgrades:
- Autolus Therapeutics (AUTL) upgraded to Buy from Neutral at Redburn Atlantic; tgt $13
- Bloom Energy (BE) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $20
- BrightView (BV) upgraded to Outperform from Mkt Perform at William Blair
- Descartes (DSGX) upgraded to Equal Weight from Underweight at Barclays; tgt raised to $125
- Independence Realty Trust (IRT) upgraded to Market Perform from Underperform at BMO Capital Markets; tgt raised to $21
-
Downgrades:
- Alexandria RE (ARE) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $112
- Bionano Genomics (BNGO) downgraded to Neutral from Buy at Ladenburg Thalmann
- Bluebirdbio (BLUE) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $0.50
- Bluebirdbio (BLUE) downgraded to Underweight from Neutral at JP Morgan
- Diamondrock Hospitality (DRH) downgraded to In-line from Outperform at Evercore ISI; tgt $10.50
- Digital Turbine (APPS) downgraded to Underperform from Neutral at BofA Securities; tgt $1
- European Wax Center (EWCZ) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt $5
- GlaxoSmithKline (GSK) downgraded to Hold from Buy at Deutsche Bank
- Gogoro (GGR) downgraded to Neutral from Buy at Citigroup; tgt lowered to $0.50
-
Others:
- AbbVie (ABBV) initiated with an Outperform at Wolfe Research; tgt $205
- Alaska Air (ALK) resumed with a Buy at Goldman; tgt $70
- Allegiant Travel (ALGT) resumed with a Neutral at Goldman; tgt $83
- American Airlines (AAL) resumed with a Neutral at Goldman; tgt $15
- Amgen (AMGN) initiated with a Peer Perform at Wolfe Research
- Biogen (BIIB) initiated with a Peer Perform at Wolfe Research
- BioMarin Pharmaceutical (BMRN) initiated with an Outperform at Wolfe Research; tgt $95
- Bristol-Myers (BMY) initiated with a Peer Perform at Wolfe Research
- CDW (CDW) initiated with a Buy at Redburn Atlantic; tgt $230
- Chipotle Mexican Grill (CMG) resumed with an Outperform at RBC Capital Mkts; tgt $70
- Comfort Systems (FIX) initiated with a Buy at Stifel; tgt $524
- Core Scientific (CORZ) initiated with a Buy at ROTH MKM; tgt $25.50
- Delta Air Lines (DAL) resumed with a Buy at Goldman; tgt $83
- Doximity (DOCS) initiated with a Neutral at Goldman; tgt $58
- EMCOR Group (EME) initiated with a Buy at Stifel; tgt $600
- Everus (ECG) initiated with a Buy at Stifel; tgt $71
- First Advantage Corp. (FA) resumed with an Outperform at RBC Capital Mkts; tgt $22
- Gilead Sciences (GILD) initiated with an Outperform at Wolfe Research; tgt $110
- GRAIL (GRAL) initiated with a Peer Perform at Wolfe Research
- HealthEquity (HQY) initiated with a Neutral at Goldman; tgt $108